Cite
HARVARD Citation
Zi, C. et al. (2020). Synthesis of (-)-epigallocatechin-3-gallate derivative containing a triazole ring and combined with cisplatin/paclitaxel inhibits NSCLC cancer cells by decreasing phosphorylation of the EGFR. Journal of chemical research. 44 (9), pp. 586-591. [Online].